Germ cell mutagenicity testing is increasingly required for chemical risk assessment. Duplex sequencing is rapidly gaining acceptance as a method to assess in vivo mutagenesis, and as a valid alternative to transgenic rodent mutation models such as the MutaMouse. We used a duplex sequencing panel of 20 genomic targets and the transgenic rodent assay to measure mutations in the germ cells of MutaMouse males exposed to 0, 1, 2, or 5 mg/kg N-ethyl-N-nitrosourea for 28 days. Germ cells from the seminiferous tubules were collected 28 days post-exposure. The transgenic rodent assay showed a significant increase in mutant frequencies at the high (P < 0.001) and medium (P = 0.01) N-ethyl-N-nitrosourea doses relative to controls, while duplex sequencing revealed a significant increase (P < 0.001) in N-ethyl-N-nitrosourea-induced mutations only at the high dose. Duplex sequencing mutation frequencies were lower in genic than in intergenic targets, suggesting a protective role for transcription-coupled repair. Interestingly, we observed several unique germ cell characteristics with respect to duplex sequencing data from rodent somatic tissues: 1) larger inter-animal variability in clonally expanded mutations that affects the ability to detect significant increases in mutation frequency; 2) a target on chromosome 2 showing much higher susceptibility to spontaneous and chemical-induced mutagenesis than other targets; and 3) a mutation spectrum consistent with that observed in the offspring of N-ethyl-N-nitrosourea-treated males but not with the spectrum in bone marrow of directly-exposed males. These results suggest that duplex sequencing is a promising approach for characterizing germ cell mutagenesis and that mutagenic mechanisms operating in germ cells differ from those in somatic tissues.
Keywords: MutaMouse; benchmark dose modelling; ecNGS; error-corrected sequencing; germ cells; mutation spectrum; mutation susceptibility; transgenic rodent assay.
© The Author(s) 2025. Published by Oxford University Press.